Terumo announces CE mark approvals for Lifepearl and Hydropearl microspheres

432

Terumo has announced that on 16 March 2015 it received CE mark for LifePearl, a new drug-eluting microsphere for chemoembolization and HydroPearl, a new microsphere for more predictable bland embolization.

Terumo has developed these products in-house so that it can continue to provide its customers with a full range of interventional oncology products for access, ablation, embolics and microspheres, a press release from the company states.

For further information Terumo can be contacted at the European Congress of Interventional Oncology (ECIO, 22– 25 April, Nice, France) and the Global Embolization Symposium and Technologies (GEST, 24– 27 June 2015, Seville, Spain) conferences.